{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:32:39Z","timestamp":1768444359731,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jdsjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jdermsci.2019.01.004","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T16:25:42Z","timestamp":1547569542000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Dyschromatosis symmetrica hereditaria and reticulate acropigmentation of Kitamura: An update"],"prefix":"10.1016","volume":"93","author":[{"given":"Michihiro","family":"Kono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2019.01.004_bib0005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/378209","article-title":"Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria","volume":"73","author":"Miyamura","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0010","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1093\/hmg\/ddt207","article-title":"Whole-exome sequencing identifies ADAM10 mutations as a cause of reticulate acropigmentation of Kitamura, a clinical entity distinct from Dowling-Degos disease","volume":"22","author":"Kono","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0015","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jid.2015.12.034","article-title":"Dyschromatosis symmetrica hereditaria and aicardi-goutieres syndrome 6 are phenotypic variants caused by ADAR1 mutations","volume":"136","author":"Kono","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0020","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1111\/jdv.14530","article-title":"ADAR1 splicing mutation leading to dyschromatosis hereditaria in a Caucasian patient","volume":"32","author":"Petre","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0025","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1365-4632.2011.05372.x","article-title":"Dyschromatosis symmetrica hereditaria by ADAR1 mutations and viral encephalitis: a hidden link?","volume":"52","author":"Kono","year":"2013","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0030","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1365-2133.1999.02716.x","article-title":"Dyschromatosis symmetrica hereditaria (reticulate acropigmentation of Dohi): report of a Japanese family with the condition and a literature review of 185 cases","volume":"140","author":"Oyama","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0035","first-page":"238","article-title":"Dyschromatosis symmetrica hereditaria--a histochemical and ultrastructural study","volume":"84","author":"Sheu","year":"1985","journal-title":"Taiwan Yi Xue Hui Za Zhi"},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0040","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1346-8138.2008.00540.x","article-title":"Dyschromatosis symmetrica hereditaria associated with neurological disorders","volume":"35","author":"Kondo","year":"2008","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0045","first-page":"267","article-title":"Analysis of genotype\/phenotype correlations in Japanese patients with dyschromatosis symmetrica hereditaria","volume":"80","author":"Kobayashi","year":"2018","journal-title":"Nagoya J. Med. Sci."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1684\/ejd.2018.3227","article-title":"Sunlight is merely a temporary modifier of dyschromatosis symmetrica hereditaria","volume":"28","author":"Kono","year":"2018","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0055","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0092-8674(88)90253-X","article-title":"An unwinding activity that covalently modifies its double-stranded RNA substrate","volume":"55","author":"Bass","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1101\/gr.164749.113","article-title":"A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes","volume":"24","author":"Bazak","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0065","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1128\/MCB.15.10.5376","article-title":"Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase","volume":"15","author":"Patterson","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0070","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1074\/jbc.M310162200","article-title":"Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene","volume":"279","author":"Wang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0075","doi-asserted-by":"crossref","first-page":"e599","DOI":"10.1038\/cddis.2013.125","article-title":"ADAR1 is essential for intestinal homeostasis and stem cell maintenance","volume":"4","author":"Qiu","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/ni.1680","article-title":"ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling","volume":"10","author":"Hartner","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0085","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/jir.2014.0001","article-title":"An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1)","volume":"34","author":"George","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.virol.2010.12.004","article-title":"Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral","volume":"411","author":"Samuel","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.jid.5700528","article-title":"Ten novel mutations of the ADAR1 gene in Japanese patients with dyschromatosis symmetrica hereditaria","volume":"127","author":"Suzuki","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1346-8138.2012.01661.x","article-title":"Dyschromatosis symmetrica hereditaria","volume":"40","author":"Hayashi","year":"2013","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0105","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1074\/jbc.M311347200","article-title":"Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1","volume":"279","author":"Hartner","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1073\/pnas.1017241108","article-title":"RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis","volume":"108","author":"Ward","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0115","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1126\/science.aac7049","article-title":"RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself","volume":"349","author":"Liddicoat","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0120","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.immuni.2015.11.001","article-title":"Isoforms of RNA-editing enzyme ADAR1 independently control nucleic acid sensor MDA5-Driven autoimmunity and multi-organ development","volume":"43","author":"Pestal","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jdermsci.2011.06.013","article-title":"An essential role of RNA editing enzyme ADAR1 in mouse skin","volume":"64","author":"Sharma","year":"2011","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0130","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.2414","article-title":"Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature","volume":"44","author":"Rice","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0135","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.celrep.2014.10.041","article-title":"The RNA-editing enzyme ADAR1 controls innate immune responses to RNA","volume":"9","author":"Mannion","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0140","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.16610","article-title":"Bilateral striatal necrosis and dyschromatosis symmetrica hereditaria: A-I editing efficiency of ADAR1 mutants and phenotype expression","author":"Kono","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0145","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/bjd.13702","article-title":"Dowling-Degos disease with mutations in POFUT1 is clinicopathologically distinct from reticulate acropigmentation of Kitamura","volume":"173","author":"Kono","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0150","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archderm.1985.01660050111027","article-title":"Behavior of melanocytes in reticulate acropigmentation of Kitamura","volume":"121","author":"Mizoguchi","year":"1985","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0155","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/pcmr.12453","article-title":"Behavior of melanocytes and keratinocytes in reticulate acropigmentation of Kitamura","volume":"29","author":"Okamura","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0160","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.mam.2008.08.001","article-title":"The ADAM metalloproteinases","volume":"29","author":"Edwards","year":"2008","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0165","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1093\/hmg\/11.21.2615","article-title":"The disintegrin\/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts","volume":"11","author":"Hartmann","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0170","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1084\/jem.20091990","article-title":"ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo","volume":"207","author":"Gibb","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0175","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm.2451","article-title":"A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice","volume":"17","author":"Inoshima","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0180","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/jid.2011.462","article-title":"Genetic requirement for ADAM10 in severe Staphylococcus aureus skin infection","volume":"132","author":"Inoshima","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0185","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1093\/hmg\/ddp323","article-title":"Potential late-onset Alzheimer\u2019s disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity","volume":"18","author":"Kim","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0190","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/482498","article-title":"The roles of ADAMs family proteinases in skin diseases","volume":"2011","author":"Kawaguchi","year":"2011","journal-title":"Enzyme Res."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0195","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1755-148X.2012.01032.x","article-title":"Adam10 haploinsufficiency causes freckle-like macules in Hairless mice","volume":"25","author":"Tharmarajah","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0200","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/500850","article-title":"Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease","volume":"78","author":"Betz","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0205","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ajhg.2013.04.022","article-title":"Mutations in POFUT1, encoding protein O-fucosyltransferase 1, cause generalized Dowling-Degos disease","volume":"92","author":"Li","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ajhg.2013.12.003","article-title":"Mutations in POGLUT1, encoding protein O-glucosyltransferase 1, cause autosomal-dominant Dowling-Degos disease","volume":"94","author":"Basmanav","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0215","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1172\/JCI90667","article-title":"Mutations in gamma-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa","volume":"127","author":"Ralser","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0220","series-title":"Pigmentation and Pigmentary Disorders","first-page":"209","article-title":"Acquired hypomelanotic disorders","author":"Levine","year":"1993"},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0225","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0190-9622(99)70498-6","article-title":"Dowling-Degos disease (reticulate pigmented anomaly of the flexures): a clinical and histopathologic study of 6 cases","volume":"40","author":"Kim","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0230","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1755-148X.2007.00423.x","article-title":"Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis","volume":"21","author":"Kumano","year":"2008","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0235","article-title":"A Japanese case of Galli\u2013Galli disease due to a previously unreported POGLUT1 mutation","author":"Kono","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0240","doi-asserted-by":"crossref","DOI":"10.1684\/ejd.2018.3415","article-title":"Dyschromatosis symmetrica hereditaria may be successfully controlled by topical sunscreen","author":"Kono","year":"2018","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0245","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/1346-8138.12205","article-title":"Patient with dyschromatosis symmetrica hereditaria treated with miniature punch grafting, followed by excimer light therapy","volume":"40","author":"Kawakami","year":"2013","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.01.004_bib0250","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0190-9622(92)70112-S","article-title":"Treatment of reticulate acropigmentation of Kitamura with azelaic acid. An immunohistochemical and electron microscopic study","volume":"26","author":"Kameyama","year":"1992","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181119300052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181119300052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T03:15:41Z","timestamp":1720926941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181119300052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0923181119300052"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2019.01.004","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dyschromatosis symmetrica hereditaria and reticulate acropigmentation of Kitamura: An update","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2019.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}